AxxessBio is pleased to share that GENCEBOK® (caffeine citrate) 10 MG/ML SOLUTION FOR INFUSION has been approved by the Health Sciences Authority (HSA) Singapore for apnoea of prematurity.
- Treatment of primary apnoea of premature newborns
GENCEBOK® is the first caffeine citrate approved in Singapore for above indication.
GENCEBOK® was also granted the European Marketing Authorization (EMA) in Aug 2020.
GENCEBOK® has the following features providing the convenience of administration and accessibility:
- Solution can be used intravenously and orally
- Optimal concentration for maintenance dose
- Pharmaceutical-grade single-use ampoule
- Room temperature storage
- Long shelf life up to 3 years
Caffeine citrate is recommended by the World Health Organization for the treatment of apnoea in preterm infants <37 weeks’ gestation.
*Please refer to the local package insert for full prescribing information.
